Limited Mobile Version
Follow this company and never miss a research update
VICO

Vicore Pharma Holding

Market Cap 414.2M
Today
Day High
27.00
24.1
Day Low
24.10
Day Open
26.20
Prev Close
24.30
VWAP
24.3
Volume
55K
Turnover
1.346M
Top Broker
GSI
VWAP
26.1
Avg Volume
53K
Avg Turnover
1.394M
Top Brokers
AVA/SHB
VWAP
26.5
Avg Volume
34K
Avg Turnover
0.897M
Top Brokers
AVA/SHB
VWAP
27.9
Avg Volume
30K
Avg Turnover
0.845M
Top Brokers
AVA/NON
52 week summary
Price Range
16.1
Last
40.0
Beta
N/A
Market Cap
414.2M
Total Return
87.6%
Trailing P/E
N/A
Div Yield
N/A%
Shares Outstanding
15.9M
Stock Exchange
First North Stockholm
5 day chart Go to advanced chart

Identify and measure trend strength in stocks with our Momentum tool to identify potential entry and exit signals. The tool provides a set of the most simple but powerful indicators that identify whether a stock is under sell or buy pressure.


Relative Price Strength
Change 3 Months -35.8%
Change 12 Months 66.4%
Volume Trend
Average Volume 10 vs 60 Days 73.6%
Price VS
52 Week High -39.8%
50 Day Moving Average -15.8%
200 Day moving Average -14.5%

Add article markers

Compare Vicore Pharma Holding to

Prev Close 0 Change 0
High 0 Avg Daily Volume 0
Low 0 Avg Daily Turnover 0
  • Management
  • Per Jansson, CEO
  • Executive board
  • Leif Darner, Chairman of the board
Source: Millistream
Major Owners Equity Votes
Protem Wessman inkl familj 14.8%
14.8%
Swedbank Robur 9.9%
9.9%
HBM Healthcare Investments (Cayman) 7.6%
7.6%
Kjell Stenberg 7.2%
7.2%
Eriksam Invest AB 5.3%
5.3%
Pomona-gruppen 5.1%
5.1%
Source: Millistream
Timeframe Transactions Net Shares
Last 12 weeks
0 Purchases
+ 0
0 Sales
- 0
Last 24 weeks
0 Purchases
+ 0
0 Sales
- 0
Report Date Name Position Transaction Shares Chg Est Value (SEK)

Catalyst Potential is behind membership

To access members-only content, you must login or register an account.

Our membership is about gaining access to unique research and knowledge through our analysts and a network of peers. Be the first to get information about news and research in the Nordic life science and technology sectors and use our tools and education to reach your personal and professional goals in investing.

Sign up Login
Source: Millistream FI
  •  
  • Profitability
  • ROE
  • ROCE
  • ROIC
  • EBITDA margin
  • EBIT margin
  • Net margin
  • Per share data (SEK)
  • EPS
  • EPS adj
  • Dividend
  • Net debt
  • Total shares
  • Valuation
  • EV (SEKm)
  • P/E
  • P/E diluted
  • P/Sales
  • EV/Sales
  • EV/EBITDA
  • EV/EBIT
  • P/BV
  • Capital structure
  • Equity ratio
  • Debt/equity ratio
  • Net debt(SEKm)
  • Capital employed(SEKm)
  • Capital turnover rate
  • (SEKm)
  • Net sales
  • Total operating costs
  • EBITDA
  • Depreciation
  • Amortization
  • Impairment charges
  • EBIT
  • Share in profits
  • Net financial items
  • Exchange rate dif.
  • Pre-tax profit
  • Tax
  • Net earnings
  • (SEKm)
  • Assets
  • Current assets
  • Cash in banks
  • Receivables
  • Inventories
  • Other current assets
  • Current assets
  • Fixed assets
  • Tangible assets
  • Associated comp.
  • Investments
  • Goodwill
  • Cap. exp. for dev.
  • O intangible rights
  • O non-current assets
  • Total fixed assets
  • Deferred tax assets
  • Total (assets)
  • Liabilities
  • Current liabilities
  • Short-term debt
  • Accounts payable
  • O current liabilities
  • Current liabilities
  • Long-term debt
  • O long-term liabilities
  • Convertibles
  • Total Liabilities
  • Deferred tax liab
  • Provisions
  • Shareholders' equity
  • Minority interest (BS)
  • Minority & equity
  • Total liab & SE
  • (SEKm)
  • Net sales
  • Total operating costs
  • Depreciations total
  • EBIT
  • Taxes on EBIT
  • NOPLAT
  • Depreciation
  • Gross cash flow
  • Change in WC
  • Gross CAPEX
  • Free cash flow

Estimated Values is behind membership

To access members-only content, you must login or register an account.

Our membership is about gaining access to unique research and knowledge through our analysts and a network of peers. Be the first to get information about news and research in the Nordic life science and technology sectors and use our tools and education to reach your personal and professional goals in investing.

Sign up Login
Source: Redeye
Source: Redeye

Presentations, research interviews and videos from our events listed here.


Source: Redeye

When selecting comparable companies, we try to group companies that are in the same or similar sector or subsector. But, more important, have growth, margins and risk characteristics similar to the company being valued.